Results 121 to 130 of about 110,409 (295)

Cytoplasmic HuR Expression Enhances Chemoresistance in Pleural Mesothelioma Through Increased Expression of CALB2, Promotion of the E2F Pathway, and Suppression of the p53 Pathway

open access: yesThoracic Cancer
Introduction Chemotherapy is crucial for treating pleural mesothelioma; however, the outcomes are poor, necessitating an urgent need to study the mechanism of chemotherapy resistance in mesothelioma cells.
Susumu Kirimura   +6 more
doaj   +1 more source

Supplementary Figure 6 from CSPG4 as a Target of Antibody-Based Immunotherapy for Malignant Mesothelioma

open access: gold, 2023
Zeyana Rivera   +8 more
openalex   +1 more source

A unified model for Duchenne muscular dystrophy gene involvement in cancer: context‐dependent tumour suppression and oncogenicity

open access: yesFEBS Open Bio, Volume 16, Issue 1, Page 222-236, January 2026.
We propose a context‐dependent model where the Duchenne muscular dystrophy (DMD) gene acts as a tumour suppressor in aggressive tumours and as an oncogene in less aggressive ones. We propose this model as a unified framework to explain the opposing survival associations with DMD expression and to guide experimental exploration of the dual role of DMD ...
Lee Machado   +4 more
wiley   +1 more source

Factors influencing malignant mesothelioma survival: a retrospective review of the National Mesothelioma Virtual Bank cohort [version 2; referees: 1 approved, 2 approved with reservations]

open access: yesF1000Research, 2018
Background: Malignant mesothelioma (MM) is a rare but deadly malignancy with about 3,000 new cases being diagnosed each year in the US.  Very few studies have been performed to analyze factors associated with mesothelioma survival, especially for ...
Waqas Amin   +4 more
doaj   +1 more source

Targeting the Dynamics Between TAMs and CAR‐T Cells in Solid Tumor Therapies

open access: yesAdvanced Science, Volume 13, Issue 1, 5 January 2026.
This review highlights the critical role of tumor‐associated macrophages (TAMs) in affecting CAR‐T cell therapy effectiveness in solid tumors. TAMs contribute to immune suppression through cytokine secretion, immune checkpoint activation, and metabolic reprogramming, leading to CAR‐T cell exhaustion and reduced efficacy. The article explores strategies
Xiang Zhang   +7 more
wiley   +1 more source

Data Supplement from Nonamplified FGFR1 Is a Growth Driver in Malignant Pleural Mesothelioma

open access: gold, 2023
Lindsay A. Marek   +12 more
openalex   +1 more source

Effectiveness of Positive Psychology Interventions for Cancer Survivors: A Systematic Review and Meta‐Analysis

open access: yesCancer Medicine, Volume 15, Issue 1, January 2026.
ABSTRACT Objectives This systematic review aimed to evaluate the effectiveness of positive psychology interventions (PPIs) that are theoretically grounded and tailored to individuals across various stages and types of cancer. Methods Adhering to PRISMA guidelines, a comprehensive search of peer‐reviewed and gray literature was conducted across seven ...
Su Ann Yeoh   +5 more
wiley   +1 more source

P1.09-003 Malignant Mesothelioma Versus Synovial Sarcoma: An Analysis of 19 Cases with Molecular Diagnosis [PDF]

open access: bronze, 2017
Sonja Klebe   +4 more
openalex   +1 more source

Supplementary Figure Legends 1-2 from Mesothelin Overexpression Promotes Mesothelioma Cell Invasion and MMP-9 Secretion in an Orthotopic Mouse Model and in Epithelioid Pleural Mesothelioma Patients [PDF]

open access: gold, 2023
Elliot L. Servais   +8 more
openalex   +1 more source

Home - About - Disclaimer - Privacy